CASI Pharmaceuticals Stock (NASDAQ: CASI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 35.00 / 238.98K |
Day Range | - - - |
52 Wk Range | 1.90 - 8.48 |
Market Cap | $83.49M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 5.99% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CASI Pharmaceuticals (NASDAQ:CASI) through any online brokerage.
Other companies in CASI Pharmaceuticals’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and Eagle Pharmaceuticals (NASDAQ:EGRX).
There is no analysis for CASI Pharmaceuticals.
CASI Pharmaceuticals has a consensus price target of $9.33.
The stock price for CASI Pharmaceuticals (NASDAQ: CASI) is $6.23 last updated July 18, 2024 at 9:29 AM EDT.
There are no upcoming dividends for CASI Pharmaceuticals.
CASI Pharmaceuticals’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for CASI Pharmaceuticals.
CASI Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.